Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer.

Nature·2026
Same author

From knowledge graph to topological data analysis: a novel framework to analyze gene regulatory networks for tomato-multi-pathogen interactions.

The New phytologist·2026
Same author

ParTIpy: a scalable framework for archetypal analysis and Pareto task inference.

Molecular systems biology·2026
Same author

Second Joint Annual Congress of the British Society of Toxicologic Pathology and the European Society of Toxicologic Pathology Special Issue.

Toxicologic pathology·2026
Same author

Patient-Centric First-in-Human Dose Selection: An Ex Vivo Minimal Anticipated Biological Effect Level Approach for T-Cell Engagers in Multiple Myeloma.

Clinical pharmacology and therapeutics·2026
Same author

Tobemstomig, a Novel Bispecific Antibody, Preferentially Blocks PD-1 and LAG-3 on CD8 TILs to Expand Stem-like T Cells for Sustained Tumor Control.

Cancer research communications·2026

Related Experiment Video

Updated: Jul 6, 2025

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

18.7K

Profiling the heterogeneity of colorectal cancer consensus molecular subtypes using spatial transcriptomics.

Alberto Valdeolivas1, Bettina Amberg2,3, Nicolas Giroud2

  • 1Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland. alberto.valdeolivas_urbelz@roche.com.

NPJ Precision Oncology
|January 10, 2024
PubMed
Summary

Spatial transcriptomics reveals colorectal cancer (CRC) subtypes and microenvironment interactions, offering insights into tumor heterogeneity and potential personalized therapies.

More Related Videos

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection
09:19

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection

Published on: July 6, 2022

4.9K
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.6K

Related Experiment Videos

Last Updated: Jul 6, 2025

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

18.7K
Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection
09:19

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection

Published on: July 6, 2022

4.9K
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.6K

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Consensus Molecular Subtypes (CMS) classify colorectal cancer (CRC) but are limited by intratumoral heterogeneity.
  • Understanding CRC's cellular and molecular composition is crucial for clinical application and personalized therapy.

Purpose of the Study:

  • To decipher the spatially resolved cellular and molecular composition of colorectal cancer (CRC).
  • To map intratumoral heterogeneity of CMS and their microenvironment.
  • To identify cell communication events at the tumor-stroma interface.

Main Methods:

  • Utilized Spatial Transcriptomics (ST) combined with single-cell RNA sequencing (scRNA-seq).
  • Analyzed the spatial distribution of cells and molecular features within CRC tumors.
  • Investigated cell-cell interactions in the tumor microenvironment.

Main Results:

  • Mapped intratumoral heterogeneity of CMS and their associated microenvironments.
  • Identified specific cell communication events in CMS2 carcinomas, including tumor growth-modulating signals.
  • Discovered potential regulation of ETV4 by DCN and PLAU-PLAUR ligand-receptor interactions at the tumor-stroma interface.

Conclusions:

  • Spatial transcriptomics (ST) is a powerful tool for resolving CRC molecular heterogeneity.
  • Characterizing the spatial architecture of CRC can advance the development of personalized therapies.
  • Understanding tumor-stroma interactions provides novel targets for CRC treatment.